These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15105140)

  • 1. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.
    Mejías A; Chávez-Bueno S; Ríos AM; Saavedra-Lozano J; Fonseca Aten M; Hatfield J; Kapur P; Gómez AM; Jafri HS; Ramilo O
    Antimicrob Agents Chemother; 2004 May; 48(5):1811-22. PubMed ID: 15105140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency.
    Mejías A; Chávez-Bueno S; Ríos AM; Aten MF; Raynor B; Peromingo E; Soni P; Olsen KD; Kiener PA; Gómez AM; Jafri HS; Ramilo O
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4700-7. PubMed ID: 16251314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice.
    Jafri HS; Chavez-Bueno S; Mejias A; Gomez AM; Rios AM; Nassi SS; Yusuf M; Kapur P; Hardy RD; Hatfield J; Rogers BB; Krisher K; Ramilo O
    J Infect Dis; 2004 May; 189(10):1856-65. PubMed ID: 15122522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Asthma and respiratory syncytial virus. New opportunities for therapeutic intervention].
    Mejías A; Chávez-Bueno S; Ríos AM; Fonseca-Aten M; Gómez AM; Jafri HS; Ramilo O
    An Pediatr (Barc); 2004 Sep; 61(3):252-60. PubMed ID: 15469810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.
    Estripeaut D; Torres JP; Somers CS; Tagliabue C; Khokhar S; Bhoj VG; Grube SM; Wozniakowski A; Gomez AM; Ramilo O; Jafri HS; Mejias A
    J Infect Dis; 2008 Nov; 198(10):1435-43. PubMed ID: 18828742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.
    Chávez-Bueno S; Mejías A; Gómez AM; Olsen KD; Ríos AM; Fonseca-Aten M; Ramilo O; Jafri HS
    Virol J; 2005 May; 2():46. PubMed ID: 15916706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
    Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A
    Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model.
    Mejías A; Chávez-Bueno S; Raynor MB; Connolly J; Kiener PA; Jafri HS; Ramilo O
    Virol J; 2007 Oct; 4():109. PubMed ID: 17961258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrafine carbon black particles enhance respiratory syncytial virus-induced airway reactivity, pulmonary inflammation, and chemokine expression.
    Lambert AL; Mangum JB; DeLorme MP; Everitt JI
    Toxicol Sci; 2003 Apr; 72(2):339-46. PubMed ID: 12655033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways.
    Piedimonte G; King KA; Holmgren NL; Bertrand PJ; Rodriguez MM; Hirsch RL
    Pediatr Res; 2000 Mar; 47(3):351-6. PubMed ID: 10709734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater
    Zhao M; Zheng ZZ; Chen M; Modjarrad K; Zhang W; Zhan LT; Cao JL; Sun YP; McLellan JS; Graham BS; Xia NS
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28539438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model.
    Caidi H; Miao C; Thornburg NJ; Tripp RA; Anderson LJ; Haynes LM
    Antiviral Res; 2018 Jun; 154():149-157. PubMed ID: 29678551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially via nerve growth factor in respiratory syncytial virus-infected mice.
    Zang N; Li S; Li W; Xie X; Ren L; Long X; Xie J; Deng Y; Fu Z; Xu F; Liu E
    Int Immunopharmacol; 2015 Sep; 28(1):121-8. PubMed ID: 26044349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude mice.
    Long X; Li S; Xie J; Li W; Zang N; Ren L; Deng Y; Xie X; Wang L; Fu Z; Liu E
    Respir Res; 2015 Feb; 16(1):11. PubMed ID: 25652021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
    Ríos AM; Mejías A; Chávez-Bueno S; Fonseca-Aten M; Katz K; Hatfield J; Gómez AM; Jafri HS; McCracken GH; Ramilo O; Hardy RD
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2897-904. PubMed ID: 15273098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus.
    Tian P; Wang Y; Liu H; Yang Y; Wu X; Wei H; Chen T
    Front Cell Infect Microbiol; 2019; 9():275. PubMed ID: 31417879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infection.
    Han J; Takeda K; Wang M; Zeng W; Jia Y; Shiraishi Y; Okamoto M; Dakhama A; Gelfand EW
    Am J Respir Cell Mol Biol; 2014 Jul; 51(1):143-54. PubMed ID: 24521403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus infections: old challenges and new opportunities.
    Mejías A; Chávez-Bueno S; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2005 Nov; 24(11 Suppl):S189-96, discussion S196-7. PubMed ID: 16378045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness.
    Schwarze J; Cieslewicz G; Joetham A; Ikemura T; Hamelmann E; Gelfand EW
    J Immunol; 1999 Apr; 162(7):4207-11. PubMed ID: 10201948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosol Delivery of Palivizumab in a Neonatal Lamb Model of Respiratory Syncytial Virus Infection.
    Edirisinghe HS; Rajapaksa AE; Royce SG; Sourial M; Bischof RJ; Anderson J; Sarila G; Nguyen CD; Mulholland K; Do LAH; Licciardi PV
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.